Displaying 10 out of 90 results

  1. When cancer strikes twice

    In many cases, the development of a second cancer resulted from the same risk factors that likely precipitated the first malignancy.
  2. Roche to buy US cancer drugmaker Ignyta for US$1.7 billion

    Swiss drugmaker Roche said on Friday it would buy U.S. cancer drugmaker Ignyta Inc for US$1.7 billion.
  3. New understanding on cancer's origin: Study

  4. Diabetes and obesity both tied to higher risk of cancer

  5. EU renews approval for herbicide glyphosate for five years

    The European Commission said on Tuesday it had renewed for five years the license for the weed-killer glyphosate, a key ingredient in Monsanto ...
  6. Amgen's Kyprolis improves overall survival in blood cancer patients

    Amgen Inc said on Monday new data from a late-stage trial testing Kyprolis in combination with two other drugs showed improved overall survival ...
  7. Novartis CAR-T therapy leads to durable response in lymphoma study

    Patients with an advanced form of an aggressive blood cancer who had initially responded to Novartis' new type of gene-modifying immunotherapy ...
  8. Poor regulation, dodgy pills spur plan for African drugs agency

    Last July, Ugandan officials seized fake versions of the cancer drug Avastin on sale in Kampala, revealing only the tip of an iceberg of bogus ...